|
Volumn 10, Issue 8, 2002, Pages 2535-2542
|
Piperidino-hydrocarbon compounds as novel non-imidazole histamine H3-receptor antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 PHENYLPROPYL 3 PIPERIDINOPROPYL ETHER;
BUT 3 YNYLBENZENE;
BUTYLLITHIUM N,N,N',N' TETRAMETHYLENE ETHYLENEDIAMINE;
CIPROXIFAN;
ETHYLENEDIAMINE DERIVATIVE;
FUB 427;
FUB 637;
GT 2227;
GT 2331;
HISTAMINE H3 RECEPTOR ANTAGONIST;
LITHIUM DERIVATIVE;
N (4 PHENYLBUT 3 YNYL)PIPERIDINE HYDROGEN OXALATE;
N (5 PHENYLHEPT 4 YNYL)PIPERIDINE HYDROGEN OXALATE;
N (5 PHENYLPENT 4 YNYL)PIPERIDINE HYDROGEN OXALATE;
N (5 PHENYLPENTYL)PIPERIDINE HYDROGEN OXALATE;
N (6 PHENYLHEX 3 ENYL)PIPERIDINE HYDROGEN OXALATE;
N (7 PHENYLHEPT 3 YNYL)PIPERIDINE;
N (7 PHENYLHEPTYL)PIPERIDINE HYDROGEN OXALATE;
N (8 PHENYLOCTYL)PIPERIDINE HYDROGEN OXALATE;
N (9 PHENYLNONYL)PIPERIDINE HYDROGEN OXALATE;
N BUT 3 YNYLPIPERIDINE HYDROGEN OXALATE;
N HEX 5 YNYLPIPERIDINE;
N OCTYLPIPERIDINE HYDROGEN OXALATE;
N PENT 4 YNYLPIPERIDINE;
N PENT 4 YNYLPIPERIDINE HYDROGEN OXALATE;
PENT 4 YNYLBENZENE;
PIPERIDINE DERIVATIVE;
THIOPERAMIDE;
UNCLASSIFIED DRUG;
ANTIHISTAMINIC AGENT;
HISTAMINE H3 RECEPTOR;
ALKYLATION;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
ANIMAL;
BIOAVAILABILITY;
CHEMISTRY;
GUINEA PIG;
ILEUM;
METABOLISM;
MOUSE;
ORAL DRUG ADMINISTRATION;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
CAVIA PORCELLUS;
SUS SCROFA;
ADMINISTRATION, ORAL;
ALKYLATION;
ANIMALS;
BIOLOGICAL AVAILABILITY;
GUINEA PIGS;
HISTAMINE ANTAGONISTS;
ILEUM;
MICE;
PIPERIDINES;
RECEPTORS, HISTAMINE H3;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0036282715
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00115-3 Document Type: Article |
Times cited : (17)
|
References (39)
|